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Rationale: Interstitial lung disease (ILD) encompasses various fibrosing lung conditions including 
idiopathic pulmonary fibrosis (IPF) and hypersensitivity pneumonitis. Changes in forced vital capacity 
(FVC) and diffusion capacity for carbon monoxide (DLCO) are the common clinical endpoints for 
prognostic monitoring and assessing treatment outcomes. Cardiopulmonary exercise testing (CPET) 
has become an important clinical measure for exercise capacity and prognosis in cardiac conditions; 
it provides assessment of the pulmonary, cardiovascular and skeletal muscle systems that cannot be 
evaluated by single organ system function. Therefore, its use in ILD remains largely unexplored. In 
this feasibility study, we investigated the use of CPET as a clinical measure in ILD and how the clinical 
variables change over time in a 30-week longitudinal study, to establish if commonly used variables 
such as FVC and DLCO change to the same extent as peak oxygen consumption (VO2peak) measured by 
CPET. 
Methods: Thirteen patients with ILD undertook incremental exercise testing to exhaustion via 
electronically braked cycle ergometer. Variables included VO2peak, FVC and DLCO. Pearson’s 
correlation coefficients established relationships between variables. Patients were brought back 30 
(± 10) weeks later for repeat testing to assess change over time. Paired samples t-tests established 
changes over time for each variable. 
Results: At first visit, six of thirteen patients (46%) reached volitional exhaustion. Six CPETs were 
terminated early due to desaturation (SpO2<88%) and one to exercise-induced right bundle branch 
block (recovery within minutes of ceasing exercise). Asymptomatic moderate exercise desaturation 
was common so we used less conservative SpO2 termination criteria (SpO2<82% or symptomatic 
desaturation) at subsequent visits. At second visit, eight of thirteen (62%) reached volitional 
exhaustion, four terminated due to symptomatic desaturation and one to poor ECG signal. The first 
visit showed a mean (± SD) FVC 83.9±18.5%, DLCO 53.3±9.3% and VO2peak 1.32±0.35 Lmin-1. FVC and 
VO2peak were significantly correlated at baseline (r=0.80, p<0.05) whilst DLCO and VO2peak were not 
(r=32, p=0.31). Repeat testing showed a reduction in FVC to 82.9±16.5% and DLCO to 50.5±9.5%, but 
an increase in VO2peak to 1.37±0.38 Lmin-1, however all changes were not significant (p>0.05). At the 
second visit, FVC and VO2peak were no longer significantly correlated (r=0.38, p>0.26) and the 
relationship between DLCO and VO2peak remained similar to baseline (r=0.33, p=0.36). 
Conclusions: Preliminary CPET results in ILD have shown independent changes in FVC and VO2peak 
over time. Further testing may therefore identify dynamic prognostic information that cannot be 
ascertained by static FVC and DLCO measures alone. 
